Author |
Adams, Paul
![]() Altes, Albert ![]() Brissot, Pierre ![]() Butzeck, Barbara ![]() Cabantchik, Ioav ![]() Cancado, Rodolfo ![]() Distante, Sonia ![]() Evans, Patricia ![]() Evans, Robert ![]() Ganz, Tomas ![]() Girelli, Domenico ![]() Hultcrantz, Rolf ![]() McLaren, Gordon ![]() Marris, Ben ![]() Milman, Nils ![]() Nemeth, Elizabeta ![]() Nielsen, Peter ![]() Pineau, Brigitte ![]() Piperno, Alberto ![]() Porto, Graca ![]() Prince, Dianne ![]() Ryan, John ![]() Sanchez, Mayka ![]() Santos, Paulo ![]() ![]() Swinkels, Dorine ![]() Teixeira, Emerencia ![]() Toska, Ketil ![]() Vanclooster, Annick ![]() White, Desley ![]() |
Abstract | Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p. Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles. |
xmlui.dri2xhtml.METS-1.0.item-coverage | New York |
Language | English |
Sponsor | La Jolla Novartis |
Date | 2018 |
Published in | Hepatology International. New York, v. 12, n. 2, p. 83-86, 2018. |
ISSN | 1936-0533 (Sherpa/Romeo, impact factor) |
Publisher | Springer |
Extent | 83-86 |
Origin |
|
Access rights | Open access ![]() |
Type | Article |
Web of Science ID | WOS:000430317500001 |
URI | https://repositorio.unifesp.br/handle/11600/55867 |
Name:
WOS000430317500001.pdf
Size: 340.5Kb Format: PDF Description: |
Open file |